๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hematopoietic Stem Cell Transplantation
Clinical trial register · China

Hematopoietic Stem Cell Transplantation Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Suzhou 4 Tianjin 2 Guangzhou 2 Zhengzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing4 Suzhou4 Tianjin2 Guangzhou2 Zhengzhou2
All 20 locations
Target enrolment
to

Hematopoietic Stem Cell Transplantation trials in China

16 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Safety and Feasibility of FMT for Immune Recovery After HSCT
NCT07755319Humoral Immunodeficiency, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 1/2
86
Suzhou
2026-08-01
Recruiting
Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients
NCT07400328Oral Mucositis, Stomatitis, Gastrointestinal Mucositis, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 2
22
Suzhu
2026-02-15
Recruiting
Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children
NCT07725263Thalassemia, Hematopoietic Stem Cell Transplantation, Neutropenia, Invasive Fungal Infections
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
Observational
30
Haikou
2026-02-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Recruiting
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
NCT07442513Hematopoietic Stem Cell Transplantation, Thrombocytopenia
First Affiliated Hospital of Zhejiang University
Phase 3
404
Hangzhou
2025-12-16
Recruiting
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation
NCT07648992Hematopoietic Stem Cell Transplantation
Daihong Liu
Phase 4
324
Beijing
2025-12-01
Recruiting
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
NCT07569653Cytomegalovirus Infections, Cytomegalovirus Disease, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
WeiShi
Phase 4
120
Beijing, Shijiazhuang, Zhengzhou, Jingzhou, Wuhan, Hohhot, Nanchang, Wenzhou
2025-10-30
Recruiting
Population PK-guided ATG Dosing in Haplo-HSCT
NCT07791576Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital
Phase 2
63
Beijing
2025-05-10
Recruiting
Tissue-resident Immune Cell Subsets in aGVHD
NCT06708507Acute Graft-versus-Host Disease, Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University
Observational
40
Guangzhou
2024-11-16
Recruiting
Prospective Clinical Trial for Children With TCRฮฑฮฒ Depleted vs Traditional Haplo Identicle HSCT
NCT06423131Graft-Versus-Host Disease, Hematopoietic Stem Cell Transplantation, Child, Only, Haploidentical Hematopoietic Stem Cell Transplantation
Sijia Gu
Not applicable
110
Shanghai
2024-05-26
Recruiting
Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
NCT06102694Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China
Observational
500
Tianjin
2023-11-16
Recruiting
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
NCT06125483Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Not applicable
38
Suzhou
2023-11-01
By invitation
Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD
NCT06698211Invasive Fungal Disease, Graft Versus Host Disease, Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China
Observational
40
Tianjin
2023-08-01
Recruiting
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
NCT05940961ALL, MRD-positive, Hematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD
Phase 2
42
Suzhou
2022-08-01
Recruiting
Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients
NCT06599346Mucositis, Hematopoietic Stem Cell Transplantation, Chemotherapy-Induced Mucositis, Radiation-Induced Mucositis
The General Hospital of Western Theater Command
Not applicable
120
Chengdu
2020-10-01
Recruiting
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
NCT04146870Nutrition, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Observational
200
Suzhou
2018-10-01
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/hematopoietic-stem-cell-transplantation

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Hematopoietic Stem Cell Transplantation.

How many Hematopoietic Stem Cell Transplantation trials are recruiting in China?

14 of the 16 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hematopoietic Stem Cell Transplantation), 16 studies
PhaseStudiesRecruitingShare
Observational6537.5%
Not applicable3318.8%
Phase 23318.8%
Phase 42212.5%
Phase 1/2106.3%
Phase 3116.3%

Most active sponsors

Lead sponsors with the most studies (Hematopoietic Stem Cell Transplantation)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Soochow University43
Institute of Hematology & Blood Diseases Hospital, China21
Chinese PLA General Hospital11
Daihong Liu11
First Affiliated Hospital of Zhejiang University11
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine11
Nanfang Hospital, Southern Medical University11
Peking University People's Hospital11
Sheng-Li Xue, MD11
Sijia Gu11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.